The Global Health Body Sounds Warning Over Critical Shortage of Weight-Loss Medications
Fewer than one in 10 individuals eligible to benefit from obesity jabs such as Wegovy can access them, states the global health agency as it releases its inaugural recommendations on the therapies.
Considering more than one billion people worldwide currently obese, it is calling for increased and just access to GLP-1 medication.
According to estimates, more than two billion could be obese by 2030 unless action is taken.
"Our new guidelines acknowledges that obesity is a long-term condition that can be treated with comprehensive and continuous care," stated its chief Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and distribution challenges are significant obstacles to universal availability to the jabs that can help people shift significant weight, says the agency.
Skinny Jab Shortage
Even in the current best projected scenario, the manufacturing of such drugs might only reach around 100 million people – fewer than 10% of those who need them, as stated by the health organization.
The advice encourages countries and companies to widen access, through approaches such as patent sharing.
The intellectual property rights on semaglutide – the main ingredient of a leading brand – is scheduled to end in multiple nations in 2026.
The Way Obesity Drugs Operate
These medications replicate a natural hormone to delay gastric emptying, curb appetite and increase satiety so people reduce food intake.
Individuals commonly see weight reduction after several weeks of starting on the regular doses.
Research suggests users may see weight return within a year of stopping the drug, as their typical food cravings come back.
Being above a healthy weight elevates your likelihood for experiencing health problems, including diabetes, cardiovascular issues, stroke, and specific cancers.
Obesity concerns individuals in every country and was responsible for over three and a half million fatalities worldwide in 2024, as per the health agency.
